111
Views
17
CrossRef citations to date
0
Altmetric
Review

A redesigned follitropin alfa pen injector for infertility: results of a market research study

, &
Pages 315-331 | Published online: 28 Jun 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Pierre Zitoun, Jaya Parikh, Martine Nijs, Wenjie Zhang, Rachel Levy-Toledano & Boxiong Tang. (2019) Analysis of patient and nurse preferences for self-administered FSH injection devices in select European markets. International Journal of Women's Health 11, pages 11-21.
Read now
Salvatore Longobardi, Anke Seidler, Julian Martins, Francois Beckers, William MacGillivray & Thomas D’Hooghe. (2019) An evaluation of the use and handling errors of currently available recombinant human follicle-stimulating hormone pen injectors by women with infertility and fertility nurses. Expert Opinion on Drug Delivery 16:9, pages 1003-1014.
Read now
Helen Saunders, Laura de la Fuente Bitaine, Chriss Eftekhar, Colin M. Howles, Johanna Glaser, Tina Hoja & Pablo Arriagada. (2018) Functionality of a novel follitropin alfa pen injector: results from human factor interactions by patients and nurses. Expert Opinion on Drug Delivery 15:6, pages 549-558.
Read now
Joan Schertz & Hilary Worton. (2018) Nurse evaluation of the redesigned fertility pen injector: a questionnaire-based observational survey. Expert Opinion on Drug Delivery 15:5, pages 435-442.
Read now
Mary Mahony, Andrea Dwyer, Raschelle Barkume, Allison Strochlic, Fabien Jeannerot & Thomas Stüdeli. (2018) US human factors engineering evaluation of an updated follitropin alfa pen injector (GONAL-f® RFF Redi-ject®) and instructions for use. Expert Opinion on Drug Delivery 15:1, pages 5-15.
Read now
Joan Schertz & Hilary Worton. (2017) Patient evaluation of the redesigned follitropin alfa pen injector. Expert Opinion on Drug Delivery 14:4, pages 473-481.
Read now
Fabien Jeannerot, Alexandra Cusin & Joan Schertz. (2016) Dose accuracy of the redesigned follitropin alfa pen injector for infertility treatment. Expert Opinion on Drug Delivery 13:12, pages 1661-1669.
Read now
Klaus Bühler. (2015) Managing infertility with the follitropin alfa prefilled pen injector – patient considerations. Therapeutics and Clinical Risk Management 11, pages 995-1001.
Read now
Peter J Illingworth, Robert Lahoud, Frank Quinn, Kendal Chidwick, Claire Wilkinson & Gavin Sacks. (2014) Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment. Patient Preference and Adherence 8, pages 813-826.
Read now
Helen Saunders, Joan C Schertz, Clara Hecker, Barbara Lang & Pablo Arriagada. (2012) The recombinant human chorionic gonadotropin prefilled pen: results of patient and nurse human factors usability testing. Expert Opinion on Drug Delivery 9:8, pages 893-900.
Read now
Colin M Howles, Diego Ezcurra & Roy Homburg. (2012) Ovarian stimulation protocols in assisted reproductive technology: an update. Expert Review of Endocrinology & Metabolism 7:3, pages 319-330.
Read now
Joan C Schertz, Helen Saunders, Clara Hecker, Barbara Lang & Pablo Arriagada. (2011) The redesigned follitropin alfa pen injector: results of the patient and nurse human factors usability testing. Expert Opinion on Drug Delivery 8:9, pages 1111-1120.
Read now

Articles from other publishers (4)

Human Fatemi, Wilma Bilger, Deborah Denis, Georg Griesinger, Antonio La Marca, Salvatore Longobardi, Mary Mahony, Xiaoyan Yin & Thomas D’Hooghe. (2021) Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007–2017). Reproductive Biology and Endocrinology 19:1.
Crossref
Bruno Lunenfeld, Wilma Bilger, Salvatore Longobardi, Veronica Alam, Thomas D'Hooghe & Sesh K. Sunkara. (2019) The Development of Gonadotropins for Clinical Use in the Treatment of Infertility. Frontiers in Endocrinology 10.
Crossref
Wilhelmina Bagchus, Özkan Yalkinoglu & Peter Wolna. (2018) Open-Label, Randomized, Two-Way, Crossover Study Assessing the Bioequivalence of the Liquid Formulation versus the Freeze-Dried Formulation of Recombinant Human FSH and Recombinant Human LH in a Fixed 2:1 Combination (Pergoveris®) in Pituitary-Suppressed Healthy Women. Frontiers in Endocrinology 8.
Crossref
Erica Fischer-Cartlidge, Sonya Romanoff, Bridgette Thom & Chasity Burrows Walters. (2016) Comparing Self-Injection Teaching Strategies for Patients With Breast Cancer and Their Caregivers: A Pilot Study. Clinical Journal of Oncology Nursing 20:5, pages 515-521.
Crossref